Full Text
P36 Can Real-World Evidence (RWE) Drive European, UK, and US Payer Decisions in the Reassessment of Oncology Therapies?

Abstract

Authors

M Bharmal I Katsoulis J Chang A Graham R Palencia A Stavropoulou C Pashos

Back to Volume 25, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×